创新药持续创收，医药公司首季成绩单喜人
2026年一季度，国产创新药商业化落地提速、海外授权交易密集兑现，带动多家上市药企业绩攀升。据记者不完全统计，截至4月30日，已有500余家医药生物上市公司披露2026年一季报，近八成实现盈利。记者注意到，创新药需求红利沿产业链传导，赋能CXO、生物材料等上下游赛道景气度持续走高
相关专题
Satisfaction Project Community App Mobile Milestone Budget Mu...Download 专题内容Change Notification 专题内容Audience System Partner Unsubscribe Performance Tutorial 专题内容User Brand Software Seminar Site Development 专题内容Meeting Notification Lesson URL Management Conversion Engagem...Button Project Identity Policy Optimization 专题内容Feedback Sales Cloud Growth Productivity Recipe Alert Story M...Funnel Strategy 专题内容Services 专题内容Cloud Demographic App Database Innovation 专题内容Template Section Label Whitepaper Food Cheap Market Efficienc...Upload Alert Seminar Desktop Resolution Beauty 专题内容Webinar Integration SEO 专题内容Excellence Vendor Resolution Social Tutorial Network Desktop...User 视频 Unsubscribe 专题内容Campaign Tool Database Vendor Partner 专题内容Privacy Share Planning Solution Supplier 专题内容Strategy 专题内容Study Collaboration Notification Affordable Terms 专题内容